{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T14:24:06Z","timestamp":1780928646520,"version":"3.54.1"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-026-03243-1","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T07:13:08Z","timestamp":1769152388000},"page":"821-823","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Toward platelet-count\u2013adaptive anticoagulation in cancer thrombocytopenia: a standards-first, equity-aware proposal"],"prefix":"10.1007","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2038-7006","authenticated-orcid":false,"given":"M.","family":"Vijayasimha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"3243_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-025-03188-x","author":"S Szmit","year":"2025","unstructured":"Szmit S, Ten Cate H, Becattini C et al (2025) Anticoagulant therapy in patients with cancer and thrombocytopenia. J Thromb Thrombolysis. https:\/\/doi.org\/10.1007\/s11239-025-03188-x. SpringerLink","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"3243_CR2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1182\/hematology.2024000551","volume":"2024","author":"F Moik","year":"2024","unstructured":"Moik F, Ay C (2024) Treatment of VTE in the thrombocytopenic cancer patient. Hematol (ASH Educ Program) 2024(1):259\u2013269. https:\/\/doi.org\/10.1182\/hematology.2024000551ASH Publications\u2009+\u20091","journal-title":"Hematol (ASH Educ Program)"},{"issue":"6","key":"3243_CR3","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.3324\/haematol.2023.284192","volume":"109","author":"R Patell","year":"2024","unstructured":"Patell R, Hsu C, Shi M et al (2024) Impact of mild thrombocytopenia on bleeding and recurrent thrombosis in cancer: post-hoc analysis of Hokusai VTE Cancer. Haematologica 109(6):1849\u20131856 https:\/\/doi.org\/10.3324\/haematol.2023.284192 Haematologica","journal-title":"Haematologica"},{"issue":"24","key":"3243_CR4","doi-asserted-by":"publisher","first-page":"5546","DOI":"10.1182\/bloodadvances.2021005966","volume":"5","author":"BJ Carney","year":"2021","unstructured":"Carney BJ, Wang TF, Ren S et al (2021) Anticoagulation in cancer-associated thromboembolism with thrombocytopenia (TROVE): a prospective, multicenter cohort. Blood Adv 5(24):5546\u20135553 (Foundational pre-2022 cohort). PubMed\u2009+\u20091 https:\/\/doi.org\/10.1182\/bloodadvances.2021005966. (Foundational pre-2022 cohort). PubMed\u2009+\u20091","journal-title":"Blood Adv"},{"key":"3243_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.thromres.2023.05.012","volume":"227","author":"TF Wang","year":"2023","unstructured":"Wang TF, Carrier M, Carney BJ, Kimpton M, Delluc A (2023) Anticoagulation management and related outcomes in patients with cancer-associated thrombosis and thrombocytopenia: a systematic review and meta-analysis. Thromb Res 227:8\u201316. https:\/\/doi.org\/10.1016\/j.thromres.2023.05.012","journal-title":"Thromb Res"},{"issue":"8","key":"3243_CR6","doi-asserted-by":"publisher","first-page":"e750","DOI":"10.1097\/HS9.0000000000000750","volume":"6","author":"A Falanga","year":"2022","unstructured":"Falanga A, Leader A, Ambaglio C et al (2022) EHA guidelines on management of antithrombotic treatments in thrombocytopenic patients with cancer. HemaSphere 6(8):e750. https:\/\/doi.org\/10.1097\/HS9.0000000000000750Lippincott Journals","journal-title":"HemaSphere"},{"issue":"5","key":"3243_CR7","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1007\/s11239-025-03085-3","volume":"58","author":"E Jalaber","year":"2025","unstructured":"Jalaber E, Orvain C, Papadopoulou V et al (2025) Management of thrombocytopenia and anticoagulant therapy in patients with hematological malignancy on chemotherapy (TAT study). J Thromb Thrombolysis 58(5):646\u2013656. https:\/\/doi.org\/10.1007\/s11239-025-03085-3PubMed","journal-title":"J Thromb Thrombolysis"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03243-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-026-03243-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03243-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T13:41:35Z","timestamp":1780926095000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-026-03243-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":7,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["3243"],"URL":"https:\/\/doi.org\/10.1007\/s11239-026-03243-1","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"23 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}